Staar lens wins CMS new technology IOL recognition
This article was originally published in The Gray Sheet
Executive Summary
Medicare will provide an additional reimbursement of $50 per lens when Staar Surgical's Afinity Collamer Aspheric foldable intraocular lens is provided to a cataract patient in an ambulatory surgical center, following the lens' designation as a new technology intraocular lens by CMS, announced March 17. To receive NTIOL recognition, an IOL must be FDA-approved with labeling and advertising consistent with the specific claim for which CMS approval is being sought, and the IOL must provide measurable, clinically meaningful improved patient outcomes over other available IOLs. The Staar Afinity IOL, which has been cleared for enhanced reimbursement through Feb. 26, 2011, reduces spheric aberrations to improve visual acuity, Staar says
You may also be interested in...
Outpatient Payment Proposal In Brief
Alcon seeks new NTIOL class: CMS says in its 2011 outpatient payment proposal, released July 2, that it is reviewing a request from Alcon Laboratories to establish a new class of new-technology intraocular lenses (NTIOL) for the firm's Acrysof Natural lenses, which use blue light filtering to improve driving safety under glare conditions. CMS notes that in 2004 it considered and rejected a request to create a separate ambulatory surgical center payment class for another intraocular lens based on blue light filtering. The agency seeks public comment on peer reviewed data that would support or disprove Alcon's claims about the device's clinical benefits, especially in the Medicare population. If a new class is created, CMS would pay an extra $50 for five years for each outpatient procedure using the lens. Since 2000, CMS has created three new NTIOL classes, including a class for lenses designed to reduce spherical aberrations to improve visual acuity; four companies with such products will continue to receive a $50 premium through Feb. 26, 2011 (1"The Gray Sheet" March 24, 2008)
Staar new-tech IOLs
Staar Surgical's Afinity Collamer Aspheric Single Piece and Elastimide Silicone intraocular lenses join the class of new technology IOLs that qualify for $50 extra payment from CMS based on improved outcomes compared with traditional lenses, the company announces July 24. The bonus payments will expire Feb. 26, 2011. Other lenses with the same special designation for reducing spherical aberrations include AMO's Tecnis, Alcon's Acrysof IQ, Bausch & Lomb's Sofport and Staar's Afinity Collamer Aspheric Three Piece (1"The Gray Sheet" March 24, 2008, In Brief). The Elastimide lens is available immediately, while the Single Piece lens will launch later this quarter, Staar says
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.